Skip to main content

Table 1 Baseline characteristics of the patients before and after the stabilised IPTW using propensity scores

From: Polymyxin B-immobilised fibre column treatment for acute exacerbation of idiopathic pulmonary fibrosis patients with mechanical ventilation: a nationwide observational study

Characteristics

All patients

Patients after IPTW estimation

PMX group

(n = 199)

%

mPSL alone group

(n = 5417)

%

SMD

PMX group

(n = 196)

%

mPSL alone group

(n = 5435)

%

SMD

Male sex

153

76.9

4014

74.1

6.5

154

78.6

4035

74.2

10.3

Age, years

          

 15–70

79

39.7

1398

25.8

29.9

51

26.0

1430

26.3

 − 0.8

 71–80

85

42.7

2412

44.5

 − 3.7

81

41.1

2420

44.5

 − 6.9

 ≥ 80

35

17.6

1607

29.7

 − 28.7

64

32.9

1585

29.2

8.1

Treatment year

         

 2010–2012

69

34.7

1604

29.6

10.9

61

31.2

1616

29.7

 − 0.8

 2013–2015

78

39.2

1924

35.5

7.6

68

34.5

1935

35.6

3.1

 2016–2018

52

26.1

1889

34.9

 − 19.1

67

34.3

1884

34.7

 − 2.2

BMI (kg/m2)

         

  < 23

69

34.7

2695

49.8

 − 30.9

94

48.2

2676

49.2

 − 2.1

  ≥ 23

98

49.2

2082

38.4

21.9

84

43.1

2111

38.8

8.6

 Missing data

32

16.1

640

11.8

12.3

17

8.7

648

11.9

 − 10.5

Hugh–Jones dyspnoea score upon admission

     

 1–4

41

20.6

1319

24.3

 − 9.0

63

32.2

1314

24.2

18.0

5

59

29.6

2532

46.7

 − 35.7

79

40.5

2500

46.0

 − 11.1

 Missing data

99

49.7

1566

28.9

43.7

53

27.2

1620

29.8

 − 5.7

Japan Coma Scale score upon admission

       

 0- or 1-digit (alert or dull)

189

95.0

5105

94.2

3.3

174

88.8

5122

94.2

 − 19.4

 2-digit (somnolence)

7

3.5

152

2.8

4.1

16

8.1

155

2.9

19.8

 3-digit (coma)

3

1.5

160

3.0

 − 9.8

6

3.1

158

2.9

0.9

Charlson Comorbidity Index

        

 0

116

58.3

2761

51.0

14.7

102

51.8

2791

51.3

0.9

 1

33

16.6

658

12.1

12.7

18

9.4

666

12.3

 − 9.2

 2

36

18.1

1299

24.0

 − 14.5

54

27.4

1289

23.7

8.5

 ≥ 3

14

7.0

699

12.9

 − 19.7

22

11.4

689

12.7

 − 4.1

Smoking index, pack-years

        

 0

76

38.2

2376

43.9

 − 11.5

94

47.7

2374

43.7

8.1

 1–39

40

20.1

1068

19.7

1.0

26

13.4

1070

19.7

 − 16.9

  ≥ 40

50

25.1

1264

23.3

4.2

50

25.7

1271

23.4

5.4

 Missing data

33

16.6

709

13.1

9.8

26

13.1

720

13.2

 − 0.3

ADL upon admission (Barthel Index)

       

 100

47

23.6

1051

19.4

10.3

46

23.5

1065

19.6

9.6

  ≤ 95

113

56.8

3327

61.4

 − 9.4

117

59.7

3329

61.3

 − 3.1

 Missing data

39

19.6

1039

19.2

1.1

33

16.7

1041

19.1

 − 6.4

History of previous hospitalisation

     

 0

116

58.3

3140

58.0

0.7

109

55.9

3156

58.1

 − 4.4

 1–2

59

29.6

1645

30.4

 − 1.6

74

37.6

1647

30.3

15.5

  ≥ 3

24

12.1

632

11.7

1.2

13

6.5

632

11.6

 − 17.9

 Academic hospital

163

81.9

4475

82.6

 − 1.8

169

86.1

4493

82.7

9.1

 ICU admission

92

46.2

1414

26.1

42.8

41

20.9

1469

27.0

 − 13.0

  1. Data are presented as n (%)
  2. IPTW, inverse probability of treatment weighting; PMX, polymyxin B-immobilised fibre column; mPSL, methylprednisolone; SMD, standardised mean difference; BMI, body mass index; ADL, activities of daily living; ICU, intensive care unit